Search the Health Library
Get the facts on diseases, conditions, tests and procedures.
I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Mouse Study Points To Potentially Powerful Tool For Treating Damaged Hearts - 04/30/2014
Mouse Study Points To Potentially Powerful Tool For Treating Damaged Hearts
May also lead to new insights into congenital heart defects
Release Date: April 30, 2014
- Cardiac progenitor cells (CPCs) are a type of cell that builds the fetal heart.
- Researchers learned of the existence of self-renewing CPCs and their microenvironment during heart formation.
- Discovery may lead to repair of damaged hearts.
A type of cell that builds mouse hearts can renew itself, Johns Hopkins researchers report. They say the discovery, which likely applies to such cells in humans as well, may pave the way to using them to repair hearts damaged by disease — or even grow new heart tissue for transplantation.
Heart tissue grown in a dish
Heart tissue grown in a dish from mouse cardiac progenitor cells (CPCs). The CPCs, and the tissue they built, were engineered to produce a red protein.
Credit: C. Kwon lab/eLife
In a study to be published in an upcoming issue of the journal eLife, the scientists also found that during heart formation, these so-called cardiac progenitor cells (CPCs) multiply without becoming heart cells in a cellular environment known as the second pharyngeal arch. This insight into the biology of CPCs may contribute to better understanding of how to prevent and treat congenital heart defects, they say.
“Our finding that CPCs are self-renewing — that they can keep dividing to form new CPCs — means they might eventually be maintained in a dish and used to make specific types of heart cells,” says Chulan Kwon, Ph.D., an assistant professor of cardiology and member of the Institute for Cell Engineering at the Johns Hopkins University School of Medicine. “Growing such cells in a dish would be an enormous step toward better treatment for heart disease.”
Kwon’s research group’s first step was figuring out the role of two genes, Numb and Numbl, in CPCs, which others’ studies had shown are needed for guiding stem and progenitor cells to their fully mature, specialized functions. Numb and Numbl are highly conserved, meaning that they’re nearly identical in mice, humans and other animals, a sign that they’re likely very important. To find out whether these genes are required for heart formation, the group disabled Numb and Numbl in early CPCs in developing mouse embryos. “The embryos failed to develop normal hearts and died at an early stage of development, showing us that Numb and Numbl are needed for CPCs to build the heart,” Kwon says.
The researchers next set out to find where CPCs live in the developing embryo. Using embryonic stem cells from mouse embryos, they again disabled Numb and Numbl while also engineering the cells to produce a glowing red protein, which would give away the CPCs’ location. But because the engineered stem cells alone wouldn’t grow into a viable embryo, the team injected them into normal mouse blastocysts — a structure formed in the early stage of mammalian development that forms both the embryo and placenta. “The normal cells in these blastocysts compensated for those that lacked Numb and Numbl, allowing the resulting embryos to survive,” Kwon says.
When the team checked the hearts of the embryos, they found the glowing red cells in the second pharyngeal arch, which is known for forming parts of the neck and face. Kwon says theirs is the first study to identify it as home to CPCs. His team took cells surrounding CPCs from this arch and grew them with CPCs in a dish. They found that the CPCs self-renewed without developing into specialized heart cells. This is an important step, he says, toward using CPCs to treat heart disease.
The next step, he says, is to coax the lab-grown CPCs to form new heart tissue that could be used to regenerate disease-damaged heart tissue. “Eventually, we might even be able to deliver cells to damaged hearts to repair heart disease,” Kwon says.
Other authors on the paper were Lincoln Shenje, Peter Andersen, Hideki Uosaki, Laviel Fernandez, Peter Rainer, Gunsik Cho, Dong-ik Lee and David Kass of The Johns Hopkins University; Weimin Zhong of Yale University; and Richard Harvey of the Victor Chang Cardiac Research Institute.
The study was supported by the Magic that Matters Fund; the National Heart, Lung and Blood Institute (grant numbers R01HL111198, R00HL092234 and HL107153); the Maryland Stem Cell Research Foundation; the Lundbeck Foundation; Fondation Leducq; the Muscular Dystrophy Association; and the Max Kade Foundation.
- Researchers Discover Dynamic Behavior of Progenitor Cells in the Brain
- Discovery of ‘Master Molecule’ Could Improve Stem Cell Treatment for Heart Attacks
- A New Path for Cardiac Stem Cells
- Stem Cell Therapy Safely Repairs Damaged Heart Muscle in Chronic Heart Failure Patients, Study Shows
On the Web:
For the Media
Photo/video files to accompany this story are available for download.
We are providing this photo/video with the understanding that it will be used only to help illustrate the story in the corresponding news release. Please also find appropriate credit information in the video caption on the press release. If there is anything else you need, please email us at JHMedia@jhmi.edu. Thank you.